Platelet large cell ratio (P-LCR) in predicting acute coronary syndromes before aspirin use
Özet
Introduction: Platelet large cell ratio (P-LCR) test is one of the test parameters that is routinely
calculated in the hemogram test, and expressed as the ratio of platelets with platelet volume
greater than 12 fL. Large platelets are relatively younger and contain more intracellular granules,
meaning that platelets have more thrombogenic potential. In the literature investigating the
relationship between the acute coronary syndrome and P-LCR levels, the use of aspirin in
patients and its effects on platelet parameters were ignored. In our study, for the first time
in the literature, the relationship between P-LCR levels and acute coronary syndromes were
investigated by means of including the patients before they took aspirin which ensures that
P-LCR test is not affected by aspirin
Atıf için künye
Tekin, E., Bayraktar, M., Çelik, M., & Özlü, İ. (2020). Platelet large cell ratio (P-LCR) in predicting acute coronary syndromes before aspirin use. Journal of Research in Clinical Medicine, 8(1), 35. https://doi.org/10.34172/jrcm.2020.035
BibTeX
@article{tekin2020-220560,
author = {Tekin, Erdal and Bayraktar, Mustafa and Çelik, Muhammet and Özlü, İbrahim},
title = {Platelet large cell ratio (P-LCR) in predicting acute coronary syndromes before aspirin use},
journal = {Journal of Research in Clinical Medicine},
year = {2020},
volume = {8},
number = {1},
pages = {35},
issn = {2717-0616},
doi = {10.34172/jrcm.2020.035},
url = {https://akademik.atauni.edu.tr/yayinlar/220560-platelet-large-cell-ratio-p-lcr-in-predicting-acute-coronary-syndromes-before}
}